| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $0 | — | — |
| R&D Expense | $312K | — | -61.4% |
| SG&A Expense | $1.3M | — | -41.8% |
| Operating Income | -$1.6M | — | -155.6% |
| Pre-tax Income | -$1.8M | — | -160.7% |
| Income Tax | $0 | — | — |
| Net Income | -$1.8M | — |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Current Assets | $3.5M | -23.6% | -68.8% |
| Total Assets | $12.8M | -9.2% | -38.3% |
| Current Liabilities | $4.5M | +14.7% | +14.7% |
| Total Liabilities | $10.7M | +5.4% | +14.6% |
| Stockholders' Equity | $2.1M | -46.6% | -81.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$1.1M | — | +28.5% |
| Investing Cash Flow | $0 | — | +100.0% |
| Financing Cash Flow | $0 | — | -100.0% |
| EPS (Basic) | -$0.29 | — | -159.2% |
| EPS (Diluted) | -$0.29 | — | -159.2% |